Not currently recruiting at UCSF
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
Summary
- Eligibility
- for males ages up to 6 years (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Paul Harmatz
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 211 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Takeda
- ID
- NCT05494593
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 5 study participants
- Last Updated